Saturday Dec 21, 2024
Saturday Dec 21, 2024
Thursday, 15 August 2024 00:00 - - {{hitsCtrl.values.hits}}
In an effort to continuously bring about some of the best world-class healthcare products and solutions to the Sri Lankan community, A. Baur & Co. Ltd, also known as Baurs, one of the country’s leading conglomerates with diversified business interests, recently entered into a partnership for the distribution of German multinational medical device company’s Sri Lankan operations, Fresenius Medical Care Lanka Ltd.
With a distinctive reputation widely regarded as an ethical, credible, and competent partner representing some of the largest and internationally well-reputed pharmaceutical brands in Sri Lanka, Baurs will strengthen and continue distributing products of Fresenius Medical Care Lanka through its extensive network backed by its state-of-the-art digital infrastructure and impactful business models.
This strategic partnership is underpinned by shared values and promising synergies that will enhance value for patients. With the high prevalence of chronic kidney diseases in Sri Lanka, accessible dialysis solutions are crucial. This collaboration between renowned leaders such as Baurs and Fresenius Medical Care Lanka will effectively meet this pressing healthcare need.
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, of which around 4.1 million patients worldwide regularly undergo dialysis treatment. It also leads the way in providing dialysis products such as dialysis machines or dialysers.
Along with its core business, the Renal Care Continuum, the company focuses on expanding into complementary areas and in the field of critical care.
Since Baurs’ foray into the healthcare sector in 1945, the division has evolved into one of the most sought-after agencies for surgical, diagnostic, and medical nutritional products with an impeccable track record for reliability, innovation, trust, and quality. Fresenius Medical Care Lanka’s partnership with Baurs is yet another testament to this.
Novartis, Roche, Sanofi, GSK, Sandoz, Nestlé Health Science, Merck, Merck Sharp and Dohme, J&J (Specialty Care), Takeda (Vaccines), Mega Life Sciences, Vitrolife, Viatris, Isispharma, Unichem, Apex, Alcon, Inova, Eisai, Rohto, Dexa Medica, and Ajanta Pharma are some of the many world-class healthcare brands that Baurs represents in Sri Lanka.
In the medical devices field, Baurs also represents renowned global manufacturers such as Medtronic, Becton Dickinson, Omron, Perkin Elmer, and Welch Allyn among others.
Baurs will uphold its highest level of governance and compliance for end-to-end activities from the manufacturer to the patient, ensuring enhanced product availability across the island and complying with industry standards in cold chain management.
Beyond business synergies, both organisations share a deep-rooted commitment to charitable causes. The Alfred and Eugénie Baur Foundation, established in honour of Alfred Baur, the Swiss visionary founder of Baurs, supports charitable endeavours and cultural preservation, mirroring the Else Kröner-Fresenius-Stiftung, which focuses on medical research and humanitarian initiatives.
These foundations underscore a shared vision of ‘Creating a Future Worth Living’ and ‘Doing what is Best for Sri Lanka’.
